<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03928522</url>
  </required_header>
  <id_info>
    <org_study_id>201811101</org_study_id>
    <nct_id>NCT03928522</nct_id>
  </id_info>
  <brief_title>Antibiotic Elution in Total Knee Arthroplasty</brief_title>
  <official_title>Prospective Randomized Study Investigating the Characterization of Antibiotics From Antibiotic Impregnated Cement After Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to characterize and quantify the level of antibiotics eluted from
      antibiotic laden cement after primary cemented total knee arthroplasty.

      Patients will be identified by medical record review to make sure they meet inclusion and
      exclusion criteria.

      Patients that qualify and sign consent will be randomized to 1 of 4 antibiotic cement groups
      which are pre-mixed tobramycin, hand-mixed tobramycin, hand mixed vancomycin, and hand-mixed
      tobramycin and hand mixed vancomycin. Study patients will be blinded to their study group.
      Intraoperative fluid from the knee prior to surgery and postoperative drain fluid from the
      knee postoperatively will be collected as well.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be identified by medical record review to make sure they meet inclusion and
      exclusion criteria.

      Patients that qualify and sign consent will be randomized to 1 of 4 antibiotic cement groups
      which are pre-mixed tobramycin, hand-mixed tobramycin, hand mixed vancomycin, and hand-mixed
      tobramycin and hand mixed vancomycin. Study patients will be blinded to their study group.
      Intraoperative fluid from the knee prior to surgery and postoperative drain fluid from the
      knee postoperatively will be collected as well.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 28, 2019</start_date>
  <completion_date type="Actual">September 30, 2019</completion_date>
  <primary_completion_date type="Actual">September 30, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>patient will not know which antibiotic cement group they are in</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Amount of antibiotics eluted from pre-mixed cement versus hand-mixed cement with tobramycin after total knee arthroplasty</measure>
    <time_frame>1 year</time_frame>
    <description>difference in elution level from pre-mixed and hand mixed antibiotics</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determine the amount of vancomycin and tobramycin eluted from hand mixed cement with both antibiotics after total knee arthroplasty</measure>
    <time_frame>1 year</time_frame>
    <description>effect of elution level of vancomycin and tobramycin together</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Total Knee Replacement</condition>
  <arm_group>
    <arm_group_label>Pre-mixed tobramycin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients will receive pre-mixed tobramycin cement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>hand mixed tobramycin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients will receive hand mixed tobramycin cement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>hand mixed vancomycin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients will receive hand mixed vancomycin cement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>hand-mixed vancomycin and tobramycin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients will receive hand mixed vancomycin and tobramycin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>hand mixed vancomycin</intervention_name>
    <description>hand mixed vancomycin powder into cement</description>
    <arm_group_label>hand mixed vancomycin</arm_group_label>
    <arm_group_label>hand-mixed vancomycin and tobramycin</arm_group_label>
    <other_name>Vancomycin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>hand mixed tobramycin</intervention_name>
    <description>hand mixed tobramycin into cement</description>
    <arm_group_label>hand mixed tobramycin</arm_group_label>
    <arm_group_label>hand-mixed vancomycin and tobramycin</arm_group_label>
    <other_name>Tobramycin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>pre-mixed tobramycin</intervention_name>
    <description>this cement is already pre-mixed with tobramycin</description>
    <arm_group_label>Pre-mixed tobramycin</arm_group_label>
    <other_name>Antibiotic PMMA bone cement</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 18

          -  Total knee arthroplasty for primary osteoarthritis performed by Dr. Rick Wright.

          -  Primary diagnosis of knee osteoarthritis

               -  Exclusion Criteria:

          -  Diminished mental capacity

          -  Vancomycin allergy

          -  Tobramycin allergy

          -  Patient history requiring IV administration of vancomycin or tobramycin
             perioperatively

          -  Chronic kidney disease stage III and stage IV
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charles Lawrie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Washington University Orthopedics</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63019</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 29, 2019</study_first_submitted>
  <study_first_submitted_qc>April 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2019</study_first_posted>
  <last_update_submitted>March 3, 2020</last_update_submitted>
  <last_update_submitted_qc>March 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Vancomycin</mesh_term>
    <mesh_term>Tobramycin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

